Aravive, Inc.
ARAVDelisted Jan 29, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001513818
Aravive, Inc. was delisted on Jan 29, 2024; its insiders filed their last Form 4 on Apr 11, 2023; 30 institutions reported holding it in 13F filings for Q4 2023, worth $825.5K in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Aravive, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Aravive, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Petrini Maria Carolina | Chief Commercial Officer | – | Apr 11, 2023 | 0 |
| Howard Rudy | Chief Financial Officer | 10,870 | Feb 2, 2023 | 0 |
| McIntyre Gail Frances | CEO and President | 65,490 | Feb 2, 2023 | 0 |
| Dove Leonard Scott | Chief Operating Officer | – | Feb 2, 2023 | 0 |
| Geller Robert B. | Chief Medical Officer | – | Feb 2, 2023 | 0 |
| Ho Peter Tai-Ching | Director | 55,353Indirect | Oct 27, 2022 | 0 |
| Zhang Eric | Director | 1,403,303Indirect | Oct 27, 2022 | 0 |
| Eshelman Fredric N | Executive Chairman | 25,517,889Indirect | Oct 26, 2022 | 0 |
| Eshelman Ventures, LLC | Director, 10% Owner | 25,517,889Indirect | Oct 26, 2022 | 0 |
| Giaccia Amato | Director | 1,213,648 | Oct 26, 2022 | 0 |
| Rogers Michael W | Director | – | Sep 26, 2022 | 0 |
| Kirk Sigurd | Director | – | Sep 26, 2022 | 0 |
| Hohneker John | Director | – | Sep 26, 2022 | 0 |
| Shah Vinay | Chief Financial Officer | – | Jan 25, 2022 | 0 |
| Rangwala Reshma | Chief Medical Officer | – | Jan 25, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 2, 2021 (view filing)7:28 PM ET | Nov 30 | 2 days | Giaccia AmatoDirector | SSale | −3.25K | $3.22 | −$10.4K | −0.3%990.2K after | 3 lots |